Budget constraints limit FDA inspections

October 09, 2010

Budgetary constraints are one of the principal factors that limit the US Food & Drug Administration's ability to conduct frequent and rigorous site inspections of pharmaceutical manufacturers, according to research published in the International Journal of Business Continuity and Risk Management.

Warren Adis, Associate Professor of Information Sciences at the Hagan School of Business, Iona College, in New Rochelle, New York, has analyzed the FDA's risk methodology used for inspecting pharmaceutical manufacturing sites and reviewed its procedures, regulations, and violations as specified in the warning letters sent out by the Administration. The period on which Adis focused is 2004 to 2009, the time during which FDA was transitioning and formalizing its new approach to site inspections. The current research re-evaluates Adis' earlier study which compares the year 2005 when the new risk methodology was incorporated into the inspection process with the year 2008, to judge the impact of this new approach.

"A review of this composite period shows a more slowly declining using of warning letters and citations, with some leveling off in the last two to three years," explains Adis. "This current review therefore presents a more balanced evaluation of FDA performance." In his assessment, Adis suggests that budgetary constraints have led the FDA to use the inspection process as a policy tool to alert manufacturers on the necessity for installing quality risk-based systems, rather than a detailed analysis of manufacturer's violations.

"By failing to specify quality assurance violations, the FDA is not providing the necessary oversight and guidance to the pharmaceutical manufacturing industry," says Adis. Furthermore, by sustaining this less than rigorous approach, the FDA may be inadvertently allowing manufacturers to take advantage of the current system and to meet quality and standards obligations by building up complaints files and the like rather than addressing the actual safety and risk issues.

Adis has previously recommended that the FDA should use its risk methodology and its 820 regulations as tools to diagnose systemic weaknesses within a given manufacturer's production processes, and then provide detailed information that must be acted on. A more invigorated 820 inspection process will preclude manufacturers from the possibility of gaming the site inspections and improve safety across the industry and its products, says Adis.
"Assessing FDA's risk methodology at pharmaceutical manufacturing sites" in the International Journal of Business Continuity and Risk Management, 2010, 1, 259-270

Inderscience Publishers

Related Business Articles from Brightsurf:

3D printing -- a 'dusty' business?
3D printers are becoming increasingly popular. They can be used to create a wide variety of three-dimensional objects based on computer templates.

Business-to-business customers expect personal service in online chat
Companies engaged in business-to-business (B2B) sales are also increasingly moving their activities online, but their online chat services and customer interaction have not been studied much yet.

Entrepreneurs have different storytelling styles for presenting business
New pioneering research shows that entrepreneurs communicate to strengthen their professional image and stakeholder relationships -- and avoid blaming others.

Gender quotas in business -- how do Europeans feel?
Despite years trying to bring more women to the top boards of business, the proportion of women on the committees of companies is tiny.

Carbon dioxide capture and use could become big business
Capturing carbon dioxide and turning it into commercial products, such as fuels or construction materials, could become a new global industry, according to a study by researchers from UCLA, the University of Oxford and five other institutions.

How NASA is becoming more business friendly
A new case study demonstrates the steps being taken by the US National Aeronautics and Space Agency (NASA) to make it easier for small businesses and entrepreneurs to understand its needs and do business with it.

Finding the 'Goldilocks' level of enthusiasm for business pitches
Georgia Institute of Technology researchers found how long an entrepreneur displays the highest level of excitement during a pitch also plays a major role in predicting success in receiving funding.

Bosses who put their followers first can boost their business
Companies would do well to tailor training and recruitment measures to encourage managers who have empathy, integrity and are trustworthy -- because they can improve productivity, according to new research from the University of Exeter Business School.

Bacteria rely on classic business model
The pneumonia causing pathogen Pseudomonas aeruginosa has developed a twin-track strategy to colonize its host.

Even small gifts boost business
If a sales agent brings their customer a small gift, the customer is much more likely to make a purchase, a study by the university of Zurich has shown.

Read More: Business News and Business Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.